Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers
about
Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samplesInnovations in proteomic profiling of cancers: alternative splice variants as a new class of cancer biomarker candidates and bridging of proteomics with structural biologyWhole human genome proteogenomic mapping for ENCODE cell line data: identifying protein-coding regionsThe emerging era of genomic data integration for analyzing splice isoform functionSpliceVista, a tool for splice variant identification and visualization in shotgun proteomics dataSpliceNet: recovering splicing isoform-specific differential gene networks from RNA-Seq data of normal and diseased samples.Application of genetic algorithms and constructive neural networks for the analysis of microarray cancer dataA new class of protein cancer biomarker candidates: differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell linesA large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signalingMapping Splicing Quantitative Trait Loci in RNA-Seq.Proteome and transcriptome profiles of a Her2/Neu-driven mouse model of breast cancer.A bioinformatics workflow for variant peptide detection in shotgun proteomicsAn integrated model of the transcriptome of HER2-positive breast cancer.Proteomic characterization of Her2/neu-overexpressing breast cancer cells.Integrating genomic, transcriptomic, and interactome data to improve Peptide and protein identification in shotgun proteomics.Revisiting the identification of canonical splice isoforms through integration of functional genomics and proteomics evidence.Functional implications of structural predictions for alternative splice proteins expressed in Her2/neu-induced breast cancers.Comparative proteomics reveals a significant bias toward alternative protein isoforms with conserved structure and function.Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins.Discovery and mass spectrometric analysis of novel splice-junction peptides using RNA-SeqFunctional Networks of Highest-Connected Splice Isoforms: From The Chromosome 17 Human Proteome Project.Strategies for Genomic and Proteomic Profiling of Cancers.Distinct splice variants and pathway enrichment in the cell-line models of aggressive human breast cancer subtypesProteogenomics.Profiling proteoforms: promising follow-up of proteomics for biomarker discovery.Differential mRNA expression profiling of oral squamous cell carcinoma by high-throughput RNA sequencing.Proteogenomics for understanding oncology: recent advances and future prospects.Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients.Annotation of Alternatively Spliced Proteins and Transcripts with Protein-Folding Algorithms and Isoform-Level Functional Networks.Identification of a novel protein isoform derived from cancer-related splicing variants using combined analysis of transcriptome and proteome.Data Analysis Pipeline for RNA-seq Experiments: From Differential Expression to Cryptic Splicing.Onco-proteogenomics: cancer proteomics joins forces with genomics.Recent Workshops of the HUPO Human Plasma Proteome Project (HPPP): A bridge with the HUPO CardioVascular Initiative and the emergence of SRM targeted proteomics
P2860
Q21092937-C66026BA-21BE-46A9-85A5-9749C10D0BFDQ27011213-D5306051-1F57-45D6-97EC-E039979CD819Q27496606-1AD21438-EEDF-4F9E-BC30-5390B6D029AEQ28242493-3CB70ECF-2D92-44A1-8FEC-FC5551FBE5A0Q30791696-8CC89AF1-8F61-40F6-8F96-8568DC0D3EF8Q30837003-0CA5D97F-3C30-4D21-BB7D-624B41C47BF8Q33941794-8EAFF0AD-15B7-43BE-A178-01E698EAC63CQ34010823-FD551582-825C-478A-A923-43C34CD1F45EQ34287704-B5DAF45C-73B4-4141-8464-2926949A801BQ34444821-82789C84-A5D1-4104-8538-B8EC4FC3CD13Q34754750-00AF5549-65A3-4BE6-9E40-6ADDC68E9EB3Q34994365-50DF5B9B-C48A-48CC-B60D-572187C31018Q35041257-A9E179A1-0590-4645-87CF-35FAA673AD8EQ35082856-43AF4BE0-E9D9-4D8D-A3D8-2BC3FAE46355Q35162490-DE8A0CCF-D342-4BD1-B002-A74C081781A4Q35213338-E043468C-B212-4ED7-9E41-6D4D2F42DA70Q35592771-ECE33D3C-2E48-466B-8C75-C0B9DE2A825FQ36179867-70BC172A-0B60-46B2-B4F1-54226330C1FFQ36992268-E2A0923B-7763-451B-9386-18E181F82E45Q37072907-1F790239-11EA-4F95-8F99-BD3E42C488DDQ37194744-D4228A33-3108-409E-9E51-48FC789180F7Q37222235-1DBCA1AA-55CF-4F22-AB0F-42428E313FCDQ37619141-88C55182-5938-4894-A16F-507557059144Q37830004-1AF8E39D-7DEE-40F5-AEE9-7142FB8B73F5Q38179449-51D3D6F7-C672-4EEC-8FCE-EFC60D6433B1Q38459082-CED8C05E-05B8-4960-8753-21C5C4F35E95Q38677257-0E4CF965-AEA8-4B86-B5C3-1A311F9A2178Q38707192-AEED2242-4EDA-4C69-AEF5-141B1E3955F1Q38985058-97E27E3D-C514-4B33-8863-F3484E97056CQ39547082-8B806B81-366B-4316-B9A6-CA92088BBD92Q42777671-D7FF65D4-17BD-473A-86DA-7D87DE8D61B1Q48256898-45E3DB8C-6BD2-47CD-9C59-B08C92811605Q57267881-E8B9D30A-EF57-4491-BCC2-2F793C7348FC
P2860
Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Proteomic characterization of ...... r 2/neu-induced breast cancers
@ast
Proteomic characterization of ...... r 2/neu-induced breast cancers
@en
type
label
Proteomic characterization of ...... r 2/neu-induced breast cancers
@ast
Proteomic characterization of ...... r 2/neu-induced breast cancers
@en
prefLabel
Proteomic characterization of ...... r 2/neu-induced breast cancers
@ast
Proteomic characterization of ...... r 2/neu-induced breast cancers
@en
P2860
P1433
P1476
Proteomic characterization of ...... r 2/neu-induced breast cancers
@en
P2093
Rajasree Menon
P2860
P304
P356
10.1158/0008-5472.CAN-09-2631
P407
P50
P577
2010-04-13T00:00:00Z